Medicure (MCUJF) Other Non-Current Assets (2009 - 2026)
Medicure's (MCUJF) quarterly Other Non-Current Assets came in at $80212.6 in Q1 2026, up 17.45% year-on-year from $68297.8 in Q1 2025, and up 2.62% quarter-over-quarter from $78162.4 in Q4 2025.
Medicure (MCUJF) Other Non-Current Assets (2009 - 2026) Analysis & Trends
Medicure's Other Non-Current Assets history runs 15 years deep, the most recent figure standing at $80212.6 for Q1 2026.
- On a quarterly basis, Other Non-Current Assets rose 17.45% year-over-year to $80212.6 in Q1 2026; TTM through Mar 2026 was $80212.6, a 17.45% increase from a year earlier, with the FY2025 full-year figure at $78013.6, up 8.99% from the prior year.
- Other Non-Current Assets rose to $80212.6 in Q1 2026 per MCUJF's latest filing, from $78162.4 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $80212.6 in Q1 2026 and bottomed at $22105.3 in Q1 2022.
- The 5-year median for Other Non-Current Assets is $56737.0 (2024), against an average of $54113.5.
- Across the five-year window, Other Non-Current Assets plunged 81.35% in 2022 and jumped 110.81% in 2023, its largest moves.
- Year by year, Other Non-Current Assets stood at $46412.3 in 2022, then rose by 18.7% to $55090.2 in 2023, then increased by 27.34% to $70153.2 in 2024, then rose by 11.42% to $78162.4 in 2025, then advanced by 2.62% to $80212.6 in 2026.
- Per Business Quant, the three latest MCUJF Other Non-Current Assets figures stand at $80212.6 (Q1 2026), $78162.4 (Q4 2025), and $68303.7 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 49.22 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.79 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 351.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 491.06 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 233.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.11 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 73.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 295.00 Mn |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn | 80,212.63 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 80,212.63 |
| Dec 31, 2025 | 78,162.40 |
| Sep 30, 2025 | 68,303.69 |
| Jun 30, 2025 | 67,119.26 |
| Mar 31, 2025 | 68,297.81 |
| Dec 31, 2024 | 70,153.22 |
| Sep 30, 2024 | 56,445.11 |
| Jun 30, 2024 | 57,028.96 |
| Mar 31, 2024 | 57,142.72 |
| Dec 31, 2023 | 55,090.16 |
| Sep 30, 2023 | 46,993.62 |
| Mar 31, 2023 | 46,600.87 |
| Dec 31, 2022 | 46,412.29 |
| Sep 30, 2022 | 23,002.39 |
| Jun 30, 2022 | 22,745.88 |
| Mar 31, 2022 | 22,105.31 |
| Dec 31, 2021 | 45,220.16 |
| Sep 30, 2021 | 45,281.33 |
| Jun 30, 2021 | 116,334.38 |
| Mar 31, 2021 | 118,514.87 |